共 50 条
- [31] A phase 2, multicenter, open-label study to evaluate the efficacy and safety of CDX-3379 in combination with cetuximab in patients with advanced head and neck squamous cell carcinoma (HNSCC).JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Bauman, Julie E.Saba, Nabil F.Adkins, DouglasWang, YingHe, YiParadise, ElsaCohen, Roger B.
- [32] An Investigator-Initiated, Prospective, Single-Center, Open-Label Clinical Study to Evaluate Safety and Performance of Intra-Articular Hyaluronic Acid (IA-HA) (Biovisc Ortho) in Patients with Osteoarthritis (OA) of the KneeCLINICAL PHARMACOLOGY-ADVANCES AND APPLICATIONS, 2021, 13 : 73 - 82Gupta, AjayChannaveera, ChethanAnand, VijenderSethi, Satyaranjan
- [33] An open-label, phase Ib/II study to evaluate the safety and efficacy of fruquintinib in combination with tislelizumab in patients with advanced triple-negative breast cancerANNALS OF ONCOLOGY, 2021, 32 : S514 - S514Tripathy, D.Ukrainskyj, S. M.Yang, Z.Kania, M.Schelman, W.Hamilton, E.
- [34] An open label phase I/Ila study to evaluate the safety and efficacy of CCS1477 as monotherapy and in combination in patients with advanced solid/metastatic tumors.JOURNAL OF CLINICAL ONCOLOGY, 2019, 37 (15)De Bono, Johann S.Cojocaru, ElenaPlummer, Elizabeth RuthKnurowski, TomaszClegg, KarenAshby, FayPegg, NeilWest, WilliamBrooks, Anthony Nigel
- [35] Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trialTRIALS, 2021, 22 (01)Gao, RuikeZhang, YingHou, WeiLi, JieZhu, GuanghuiZhang, XiaoxiaoXu, BowenWu, ZheWang, Heping
- [36] Combination of first-line chemotherapy with Kanglaite injections versus first-line chemotherapy alone for advanced non-small-cell lung cancer: study protocol for an investigator-initiated, multicenter, open-label, randomized controlled trialTrials, 22Ruike GaoYing ZhangWei HouJie LiGuanghui ZhuXiaoxiao ZhangBowen XuZhe WuHeping Wang
- [37] A Prospective, Multicentre, Open-Label Single-Arm Exploratory Study to Evaluate Efficacy and Safety of Saroglitazar on Hypertriglyceridemia in HIV Associated LipodystrophyPLOS ONE, 2016, 11 (01):Deshpande, AlkaToshniwal, HarshJoshi, ShashankJani, Rajendrakumar H.
- [38] A phase 2, open-label, multicenter study to evaluate the efficacy, safety, and tolerability of KN046 in combination with chemotherapy in subjects with advanced non-small cell lung cancer.JOURNAL OF CLINICAL ONCOLOGY, 2021, 39 (15)Yang, YunpengFang, WenfengHuang, YanLi, XingyaHuang, SiyuanWu, JingxunLi, YibinChang, BaopingHu, ShengYang, ShujunXu, JuneVan, HardyZhi, LihuaXia, YueYang, FeiXia, YiKong, PaulDong, WeiXu, TingZhang, Li
- [39] An open label phase I study to evaluate the safety and efficacy of OBP-301 with pembrolizumab in patients with advanced solid tumors.JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)Kojima, TakashiFujiwara, ToshiyoshiShirakawa, YasuhiroOno, HiromiNakamoto, MasakoHasegawa, HiromiHirano, NamiWakabayashi, MasashiNomura, ShogoTogashi, YosukeNishikawa, HiroyoshiSato, AkihiroOhtsu, AtsushiDoi, Toshihiko
- [40] Preliminary Safety and Efficacy from a Multicenter, Investigator-Initiated Phase II Study in Untreated TP53 Mutant Mantle Cell Lymphoma with Zanubrutinib, Obinutuzumab, and Venetoclax (BOVen)BLOOD, 2021, 138Kumar, AnitaSoumerai, Jacob D.Abramson, Jeremy S.Batlevi, Connie LeeChadha, PujaDogan, AhmetFalchi, LorenzoFlaherty, KelseyFriedman, ChayaGrieve, ClareHo, CalebJohnson, P. ConnorJoseph, AshleeKhan, NilouferMi, JoannaMartignetti, RosalbaMatasar, Matthew J.Owens, ColetteRuiters, JadeSechio, SidneySeshan, VenkatramanSimkins, ElizabethAbdel-Wahab, OmarZelenetz, Andrew D.